Advanced Cell Technology and Catholic Healthcare West Sign Clinical Agreement
Catholic Healthcare West to become Advanced Cell Technology’s first clinical trial site for Phase II myoblast study LOS ANGELES, Calif….
Catholic Healthcare West to become Advanced Cell Technology’s first clinical trial site for Phase II myoblast study LOS ANGELES, Calif….
Agreement Represents Progress Toward Commencing Phase II Human Clinical Trials for Myoblast Therapy Los Angeles, CA, March 5, 2008 –…
Company Makes Progress on Multiple Therapeutic Fronts Worcester, MA, February 21, 2008 – Advanced Cell Technology, Inc.(OTCBB: ACTC – News) reported today for…
New, scalable population of hemangioblast cells halves the death rate following heart attack and repairs ischemic limbs and damaged vasculature….
Landmark Merger of Embryonic Stem Cell Patent Estates Alameda, CA, February 8, 2007 – Advanced Cell Technology, Inc. (OTCBB: ACTC) announced…
Landmark Merger of Embryonic Stem Cell Patent Estates Alameda, CA, February 8, 2007 – Advanced Cell Technology, Inc. (OTCBB: ACTC)…
Transplanted Cells Shown Capable of Rescuing Photoreceptor Cells in RCS Rats with Retinal Disease Worcester, MA, September 21, 2006—Advanced Cell…
Agreement Subject to U.S. Federal Government Recognition and Funding of Cell Lines Madison, Wis. and Alameda, Ca., September 12, 2006—The…
Testimony Discusses How Company’s Technique for Human Stem Cell Development May Advance Support for Stem Cell Research Worcester, MA, September…
Alameda, CA, August 22, 2006—Advanced Cell Technology, Inc. (OTCBB:ACTC) announced today plans to privately offer up to $11,295,000 of senior…